Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Therapy Name | DSP-0337 |
Synonyms | |
Therapy Description |
DSP-0337 is a prodrug of napabucasin, which inhibits Stat3 signaling and may potentially lead to tumor growth inhibition (NCI Drug Dictionary). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
DSP-0337 | DSP-0337 is a prodrug of napabucasin, which inhibits Stat3 signaling and may potentially lead to tumor growth inhibition (NCI Drug Dictionary). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT03416816 | Phase I | DSP-0337 | A Study of DSP-0337 in Patients With Advanced Solid Tumors to Determine the Safety and the Pharmacokinetic Profile | Terminated | USA | 0 |